453 related articles for article (PubMed ID: 27083409)
1. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
Dyson JK; Rutter MD
World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
Kim ER; Chang DK
World J Gastroenterol; 2014 Aug; 20(29):9872-81. PubMed ID: 25110418
[TBL] [Abstract][Full Text] [Related]
4. Chromoendoscopy for Surveillance in Inflammatory Bowel Disease Does Not Increase Neoplasia Detection Compared With Conventional Colonoscopy With Random Biopsies: Results From a Large Retrospective Study.
Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; Fidder HH; Siersema PD; Dekker E; Oldenburg B
Am J Gastroenterol; 2015 Jul; 110(7):1014-21. PubMed ID: 25823770
[TBL] [Abstract][Full Text] [Related]
5. Dysplasia and cancer in inflammatory bowel disease.
Basseri RJ; Basseri B; Papadakis KA
Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):59-66. PubMed ID: 21309672
[TBL] [Abstract][Full Text] [Related]
6. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory bowel disease as a risk factor for colorectal cancer.
Lukas M
Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk.
Herszényi L; Barabás L; Miheller P; Tulassay Z
Dig Dis; 2015; 33(1):52-7. PubMed ID: 25531497
[TBL] [Abstract][Full Text] [Related]
9. Colorectal Cancer Screening in Inflammatory Bowel Disease.
Sengupta N; Yee E; Feuerstein JD
Dig Dis Sci; 2016 Apr; 61(4):980-9. PubMed ID: 26646250
[TBL] [Abstract][Full Text] [Related]
10. Surveillance strategies in inflammatory bowel disease.
Schmidt C; Bielecki C; Felber J; Stallmach A
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):189-201. PubMed ID: 20485256
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer surveillance in inflammatory bowel disease: Practice guidelines and recent developments.
Clarke WT; Feuerstein JD
World J Gastroenterol; 2019 Aug; 25(30):4148-4157. PubMed ID: 31435169
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer in inflammatory bowel disease: review of the evidence.
Keller DS; Windsor A; Cohen R; Chand M
Tech Coloproctol; 2019 Jan; 23(1):3-13. PubMed ID: 30701345
[TBL] [Abstract][Full Text] [Related]
13. Chronic inflammatory bowel disease and cancer.
Pohl C; Hombach A; Kruis W
Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
[TBL] [Abstract][Full Text] [Related]
14. Dysplasia and colorectal cancer in inflammatory bowel disease: a result of inflammation or an intrinsic risk?
Breynaert C; Vermeire S; Rutgeerts P; Van Assche G
Acta Gastroenterol Belg; 2008; 71(4):367-72. PubMed ID: 19317276
[TBL] [Abstract][Full Text] [Related]
15. Endoscopy/surveillance in inflammatory bowel disease.
Ahmadi AA; Polyak S
Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
[TBL] [Abstract][Full Text] [Related]
16. Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease.
Aalykke C; Jensen MD; Fallingborg J; Jess T; Langholz E; Meisner S; Andersen NN; Riis LB; Thomsen OØ; Tøttrup A
Dan Med J; 2015 Jan; 62(1):B4995. PubMed ID: 25557336
[TBL] [Abstract][Full Text] [Related]
17. Updates in colorectal cancer screening in inflammatory bowel disease.
Clarke WT; Feuerstein JD
Curr Opin Gastroenterol; 2018 Jul; 34(4):208-216. PubMed ID: 29771698
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation in inflammatory bowel disease - surveillance guide.
Stallmach A; Bielecki C; Schmidt C
Dig Dis; 2009; 27(4):584-90. PubMed ID: 19897979
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
Ahmadi A; Polyak S; Draganov PV
World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
[TBL] [Abstract][Full Text] [Related]
20. A rule for determining risk of colorectal cancer in patients with inflammatory bowel disease.
Lutgens M; Vermeire S; Van Oijen M; Vleggaar F; Siersema P; van Assche G; Rutgeerts P; Oldenburg B;
Clin Gastroenterol Hepatol; 2015 Jan; 13(1):148-54.e1. PubMed ID: 25041864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
